Pharmaceutical technology offers several options for protecting substances from acidic environments, such as encapsulation in enteric capsules or dosage form with enteric coating. However, commercial enteric capsules do not always meet limits for pharmacopeial delayed release, and the coating process is generally challenging. Preparing small enteric batches suitable for clinical use is, therefore, an unsolved problem. This experiment offers a simple coating process of DRcaps capsules based on hypromellose (HPMC) and gellan gum to achieve small intestine administration. In addition, DRcaps capsules were compared to hard gelatin capsules to evaluate the suitability of the coating method. Both capsules were immersed in dispersions of Eudragit S 100, Acryl-EZE and Cellacefate at concentrations of 10.0, 15.0, and 20.0% and dried. Coated capsules were evaluated by electron microscopy, disintegration, and dissolution test with a two-step pH change (from 1.2 to 6.8, then to 7.5) to simulate passage through the digestive tract. DRcaps capsules coated with Eudragit S and Cellacefate achieved acid resistance. While samples coated with Eudragit S released their contents within 360 min at pH 6.8 (small intestine), regardless of polymer concentration, capsules with 15.0 and 20.0% coatings of Cellacefate released content at pH 7.5 (colon) within 435 and 495 min, respectively.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414254 | PMC |
| http://dx.doi.org/10.3390/pharmaceutics14081577 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development and evaluation of innovative enteric-coated capsules for colon-specific delivery of hydrophilic biomaterials.
Int J Pharm
January 2025
Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno 612 00, Czech Republic.
Objective: This research aims to design and evaluate an enteric-coated hard capsule dosage form for targeted delivery of biological materials, such as FMT (fecal microbiota transplant) or live microbes, to the distal parts of the GIT. The capsules are designed to be internally protected against destruction by hydrophilic filling during passage through the digestive tract.
Methods: Hard gelatin capsules and DRcapscapsules based on HPMC and gellan were used to encapsulate a hydrophilic body temperature-liquefying gelatin hydrogel with caffeine or insoluble iron oxide mixture.
Exploring Immersion Coating as a Cost-Effective Method for Small-Scale Production of Enteric-Coated Gelatin Capsules.
Pharmaceuticals (Basel)
March 2024
School of Pharmacy, University of Camerino, 62032 Camerino, Italy.
The coating process for solid dosage forms is widely used in the pharmaceutical industry but presents challenges for small-scale production, needed in personalized medicine and clinical or galenic settings. This study aimed to evaluate immersion coating, a cost-effective small-scale method, for enteric-coated gelatin capsules using standard equipment. Two enteric coating polymers and different polymer concentrations were tested, along with API solubility.
View Article and Find Full Text PDFA Deep Learning Model Based on Capsule Networks for COVID Diagnostics through X-ray Images.
Diagnostics (Basel)
September 2023
Centro de Investigacion en Matematicas, Guanajuato 36000, Mexico.
X-ray diagnostics are widely used to detect various diseases, such as bone fracture, pneumonia, or intracranial hemorrhage. This method is simple and accessible in most hospitals, but requires an expert who is sometimes unavailable. Today, some diagnoses are made with the help of deep learning algorithms based on Convolutional Neural Networks (CNN), but these algorithms show limitations.
View Article and Find Full Text PDFCommercially Available Enteric Empty Hard Capsules, Production Technology and Application.
Pharmaceuticals (Basel)
November 2022
Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, 612 42 Brno, Czech Republic.
Currently, there is a growing need to prepare small batches of enteric capsules for individual therapy or clinical evaluation since many acidic-sensitive substances should be protected from the stomach's acidic environment, including probiotics or fecal material, in the fecal microbiota transplantation (FMT) process. A suitable method seems to be the encapsulation of drugs or lyophilized alternatively frozen biological suspensions in commercial hard enteric capsules prepared by so-called Enteric Capsule Drug Delivery Technology (ECDDT). Manufacturers supply these types of capsules, made from pH-soluble polymers, in products such as AR Caps, EnTRinsic, and Vcaps Enteric, or capsules made of gelling polymers that release their content as the gel erodes over time when passing through the digestive tract.
View Article and Find Full Text PDFDevelopment and Comparison of Various Coated Hard Capsules Suitable for Enteric Administration to Small Patient Cohorts.
Pharmaceutics
July 2022
Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, 612 42 Brno, Czech Republic.
Pharmaceutical technology offers several options for protecting substances from acidic environments, such as encapsulation in enteric capsules or dosage form with enteric coating. However, commercial enteric capsules do not always meet limits for pharmacopeial delayed release, and the coating process is generally challenging. Preparing small enteric batches suitable for clinical use is, therefore, an unsolved problem.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!